Additional biological samples
Sponsors
Centre Hospitalier Universitaire de Besancon
Conditions
Anal Canal CancerCancerChronic LeukemiaElderlyHealthy AgingHematological Malignancies BMetastatic CancerMetastatic Colorectal Cancer
Unknown Phase
Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer
CompletedNCT02817178
Start: 2013-03-31End: 2020-07-06Updated: 2022-05-11
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
CompletedNCT02818907
Start: 2016-05-19End: 2023-07-07Updated: 2024-09-19
Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer
CompletedNCT02838381
Start: 2012-06-30End: 2024-06-11Updated: 2024-12-27
Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor
CompletedNCT02842333
Start: 2016-05-31End: 2020-10-06Updated: 2025-05-25
Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B
TerminatedNCT02844491
Start: 2013-01-22End: 2014-09-19Updated: 2021-02-02
Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma
WithdrawnNCT03942900
Start: 2020-04-01End: 2024-04-30Updated: 2021-07-30
Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)
NCT04365322
Start: 2020-04-20End: 2025-04-20Target: 160Updated: 2020-07-14
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793
Start: 2021-04-15End: 2023-03-25Target: 300Updated: 2021-06-08